6 Phase II, multi-centre, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV

Journal of Hepatology(2006)

Cited 7|Views7
No score
Key words
gastroenterology,medical sciences
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined